Baxter International Inc. Files 8-K for Regulation FD Disclosure
Ticker: BAX · Form: 8-K · Filed: Oct 9, 2024 · CIK: 10456
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: BAX
TL;DR
Baxter filed an 8-K for a Reg FD disclosure on Oct 8th.
AI Summary
Baxter International Inc. announced on October 8, 2024, that it is providing a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a current report filed under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates Baxter International Inc. is making a public disclosure under Regulation FD, which ensures fair and timely dissemination of material information to all investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Baxter International Inc. (company) — Registrant
- October 8, 2024 (date) — Date of earliest event reported
- Regulation FD (regulation) — Type of disclosure
FAQ
What specific information is Baxter International Inc. disclosing under Regulation FD?
The provided filing is a Form 8-K indicating a Regulation FD Disclosure, but it does not specify the content of the disclosure itself.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on October 8, 2024.
What is the purpose of a Regulation FD Disclosure?
A Regulation FD Disclosure is made to ensure that material information is broadly disseminated to the public in an effort to prevent selective disclosure.
Under which section of the Securities Exchange Act is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Baxter International Inc.'s state of incorporation?
Baxter International Inc. is incorporated in Delaware.
Filing Stats: 1,066 words · 4 min read · ~4 pages · Grade level 15.3 · Accepted 2024-10-09 09:15:21
Key Financial Figures
- $1.00 — ange on which registered Common Stock, $1.00 par value BAX (NYSE) New York Stock Exc
Filing Documents
- bax-20241008.htm (8-K) — 30KB
- 0001628280-24-042579.txt ( ) — 223KB
- bax-20241008.xsd (EX-101.SCH) — 4KB
- bax-20241008_def.xml (EX-101.DEF) — 19KB
- bax-20241008_lab.xml (EX-101.LAB) — 35KB
- bax-20241008_pre.xml (EX-101.PRE) — 20KB
- bax-20241008_htm.xml (XML) — 6KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On September 29, 2024, Baxter International Inc., a Delaware corporation (the "Company" or "Baxter") issued a press release regarding the impact of Hurricane Helene, which brought unprecedented rain and extensive flooding to Western North Carolina, on the operations of its North Cove facility in Marion, N.C. Baxter's North Cove facility was affected by flooding due to the storm and is currently closed for production while the Company undertakes related remediation efforts. The Company is actively working with customers, regulators and other stakeholders to manage inventory and minimize disruption to patient care as it works to fully restore its North Cove manufacturing operations. This work includes implementing allocations, which limit customer orders based on historical ordering and medical necessity as well as available and projected inventory, reallocating capacity from certain other Baxter facilities and working with U.S. Food and Drug Administration to provide for the temporary importation of certain Baxter products. On October 8, 2024, based on the current status of its remediation efforts and the Company's expectations of its ability to reallocate capacity from certain other Baxter facilities and to initiate temporary importation on certain products, Baxter shared that its goal is to restart North Cove production in phases and to be at 90% to 100% allocation of certain intravenous solution product codes by the end of 2024. The Company plans on providing periodic updates regarding the status of its remediation efforts and supply continuity matters on its website (www.baxter.com/baxter-newsroom/hurricane-helene-updates) and to provide other updates (including with respect to the related estimated financial impact on its operations) as part of its third quarter earnings announcement. This Form 8-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including